Pulmonary Artery Pressure, Gender, Menopause, and Pregnancy in Schistosomiasis-associated Pulmonary Hypertension

Overview

Journal Arq Bras Cardiol

Specialty Cardiology & Vascular Diseases

Date 2013 Jul 4

PMID 23821406

Citations 2

Authors

Anderson C Armstrong

Angela M P Bandeira

Luis C L Correia

Humberto C O Melo

Carlos A M Silveira

Eugenio Albuquerque

Jeova C Moraes Jr

Antonio M L Silva

Joao A C Lima

Dario C Sobral Filho

Affiliations

Soon will be listed here.

Abstract

Background: Schistosomiasis-associated pulmonary arterial hypertension (SPAH) is a major concern worldwide. However, the role of gender-specific contributing factors in SPAH is unknown.

Objective: We investigated how systolic pulmonary artery pressure (SPAP) values and the presence of severe SPAP relate to gender, menopausal status, and pregnancy history in SPAH patients.

Methods: Seventy-nine patients diagnosed with SPAH from 2000 to 2009 were assessed and 66 were enrolled in the study. Information about age, menopausal status, pregnancy, echocardiography-derived SPAP, and invasive mean pulmonary artery pressure (mPAP) was collected from medical records. The relation between values of SPAP and mPAP and their agreement for severe disease were assessed. Regression models assessed the association of gender, menopausal status, and pregnancy history with SPAP values and the presence of severe SPAP.

Results: Moderate correlation and good agreement for severe disease were found between mPAP and SPAP. Mean SPAP values were similar for men and women. A trend toward higher values of SPAP was found for non-menopausal women compared to men. Higher SPAP values were found for menopausal compared to non-menopausal women; the values were non-significant after adjustment for age. Pregnancy history had no association with SPAP. Menopause and positive pregnancy had no association with severe SPAP.

Conclusion: In SPAH patients, neither gender, nor menopausal status, nor pregnancy history showed independent correlation with SPAP values assessed by echocardiography.

Citing Articles

Hypothesis: Neuroendocrine Mechanisms (Hypothalamus-Growth Hormone-STAT5 Axis) Contribute to Sex Bias in Pulmonary Hypertension.

Sehgal P, Yang Y, Miller E Mol Med. 2015; 21(1):688-701.

PMID: 26252185 PMC: 4749490. DOI: 10.2119/molmed.2015.00122.

Myocardial delayed enhancement by cardiac magnetic resonance imaging in Pulmonary Arterial Hypertension: a marker of disease severity.

Rochitte C, Hoette S, Souza R Arq Bras Cardiol. 2013; 101(5):377-8.

PMID: 24343552 PMC: 4081160. DOI: 10.5935/abc.20130224.

References

Kuppahally S, Michaels A, Tandar A, Gilbert E, Litwin S, Bader F . Can echocardiographic evaluation of cardiopulmonary hemodynamics decrease right heart catheterizations in end-stage heart failure patients awaiting transplantation?. Am J Cardiol. 2010; 106(11):1657-62. DOI: 10.1016/j.amjcard.2010.07.022. View

Ross A, Bartley P, Sleigh A, Olds G, Li Y, Williams G . Schistosomiasis. N Engl J Med. 2002; 346(16):1212-20. DOI: 10.1056/NEJMra012396. View

Pyxaras S, Pinamonti B, Barbati G, Santangelo S, Valentincic M, Cettolo F . Echocardiographic evaluation of systolic and mean pulmonary artery pressure in the follow-up of patients with pulmonary hypertension. Eur J Echocardiogr. 2011; 12(9):696-701. DOI: 10.1093/ejechocard/jer127. View

Ferreira R, Domingues A, Bandeira A, Markman Filho B, Albuqerque Filho E, Correiade de Araujo A . Prevalence of pulmonary hypertension in patients with schistosomal liver fibrosis. Ann Trop Med Parasitol. 2009; 103(2):129-43. DOI: 10.1179/136485909X398168. View

Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V . Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006; 173(9):1023-30. DOI: 10.1164/rccm.200510-1668OC. View

Fisher M, Criner G, Fishman A, Hassoun P, Minai O, Scharf S . Estimating pulmonary artery pressures by echocardiography in patients with emphysema. Eur Respir J. 2007; 30(5):914-21. DOI: 10.1183/09031936.00033007. View

DAlonzo G, Barst R, Ayres S, Bergofsky E, Brundage B, Detre K . Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991; 115(5):343-9. DOI: 10.7326/0003-4819-115-5-343. View

Graham B, Bandeira A, Morrell N, Butrous G, Tuder R . Schistosomiasis-associated pulmonary hypertension: pulmonary vascular disease: the global perspective. Chest. 2010; 137(6 Suppl):20S-29S. PMC: 5989787. DOI: 10.1378/chest.10-0048. View

Tramarin R, Torbicki A, Marchandise B, Laaban J, Morpurgo M . Doppler echocardiographic evaluation of pulmonary artery pressure in chronic obstructive pulmonary disease. A European multicentre study. Working Group on Noninvasive Evaluation of Pulmonary Artery Pressure. European Office of the World Health.... Eur Heart J. 1991; 12(2):103-11. DOI: 10.1093/oxfordjournals.eurheartj.a059855. View

10.

Lahm T, Patel K, Crisostomo P, Markel T, Wang M, Herring C . Endogenous estrogen attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction: the effects of sex and menstrual cycle. Am J Physiol Endocrinol Metab. 2007; 293(3):E865-71. DOI: 10.1152/ajpendo.00201.2007. View

11.

Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J . Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis. 2006; 6(7):411-25. DOI: 10.1016/S1473-3099(06)70521-7. View

12.

Lapa M, Dias B, Jardim C, Fernandes C, Dourado P, Figueiredo M . Cardiopulmonary manifestations of hepatosplenic schistosomiasis. Circulation. 2009; 119(11):1518-23. DOI: 10.1161/CIRCULATIONAHA.108.803221. View

13.

Ristow B, Schiller N . Stepping away from ritual right heart catheterization into the era of noninvasively measured pulmonary artery pressure. J Am Soc Echocardiogr. 2009; 22(7):820-2. DOI: 10.1016/j.echo.2009.05.023. View

14.

Lam C, Borlaug B, Kane G, Enders F, Rodeheffer R, Redfield M . Age-associated increases in pulmonary artery systolic pressure in the general population. Circulation. 2009; 119(20):2663-70. PMC: 2753443. DOI: 10.1161/CIRCULATIONAHA.108.838698. View

15.

Taraseviciute A, Voelkel N . Severe pulmonary hypertension in postmenopausal obese women. Eur J Med Res. 2006; 11(5):198-202. View

16.

Lopes A, Bandeira A, Flores P, Santana M . Pulmonary hypertension in Latin America: pulmonary vascular disease: the global perspective. Chest. 2010; 137(6 Suppl):78S-84S. DOI: 10.1378/chest.09-2960. View

17.

Gaine S, Rubin L . Primary pulmonary hypertension. Lancet. 1998; 352(9129):719-25. DOI: 10.1016/S0140-6736(98)02111-4. View

18.

Weiss B, Zemp L, Seifert B, Hess O . Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol. 1998; 31(7):1650-7. DOI: 10.1016/s0735-1097(98)00162-4. View

19.

Scorza R, Caronni M, Bazzi S, Nador F, Beretta L, Antonioli R . Post-menopause is the main risk factor for developing isolated pulmonary hypertension in systemic sclerosis. Ann N Y Acad Sci. 2002; 966:238-46. DOI: 10.1111/j.1749-6632.2002.tb04221.x. View

20.

Badano L, Ginghina C, Easaw J, Muraru D, Grillo M, Lancellotti P . Right ventricle in pulmonary arterial hypertension: haemodynamics, structural changes, imaging, and proposal of a study protocol aimed to assess remodelling and treatment effects. Eur J Echocardiogr. 2009; 11(1):27-37. DOI: 10.1093/ejechocard/jep152. View